Activist 13D/13G Filings - PIERIS PHARMACEUTICALS INC. (PIRS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-14
09:07 am
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Lynx1 Capital Management LP37,436
2.800%
-9,738,413decrease
(-99.62%)
View
2024-08-01
08:00 am
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
ADAR1 Capital Management LLC138,641
10.500%
138,641increase
(New Position)
View
2024-05-17
5:07 pm
Unchanged
13GPIERIS PHARMACEUTICALS INC.
PIRS
BIOTECHNOLOGY VALUE FUND L P257,622
19.500%
0
(Unchanged)
View
2024-05-17
5:07 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
BIOTECHNOLOGY VALUE FUND L P257,622
19.500%
257,622increase
(New Position)
View
2024-02-14
4:37 pm
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Aquilo Capital Management LLC1,126,761
1.100%
-4,552,876decrease
(-80.16%)
View
2024-02-14
1:12 pm
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Checkpoint Capital L.P.0
0.000%
-4,938,486decrease
(Position Closed)
View
2024-02-14
09:19 am
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Lynx1 Capital Management LP9,775,849
9.900%
4,147,264increase
(+73.68%)
View
2024-02-02
09:59 am
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Soleus Capital Master Fund L.P.0
0.000%
-4,000,000decrease
(Position Closed)
View
2023-08-17
4:49 pm
Unchanged
13DPIERIS PHARMACEUTICALS INC.
PIRS
BIOTECHNOLOGY VALUE FUND L P20,609,863
20.800%
0
(Unchanged)
View
2023-06-09
5:40 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Checkpoint Capital L.P.4,938,486
6.000%
4,938,486increase
(New Position)
View
2023-05-22
4:47 pm
Purchase
13DPIERIS PHARMACEUTICALS INC.
PIRS
BIOTECHNOLOGY VALUE FUND L P20,609,863
22.000%
12,915,803increase
(+167.87%)
View
2023-02-14
4:06 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Lynx1 Capital Management LP5,628,585
7.600%
1,803,966increase
(+47.17%)
View
2023-02-14
11:28 am
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Aquilo Capital Management LLC5,679,637
7.500%
1,356,349increase
(+31.37%)
View
2023-02-13
8:14 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
BIOTECHNOLOGY VALUE FUND L P7,694,060
9.990%
287,417increase
(+3.88%)
View
2023-02-10
4:20 pm
Unchanged
13GPIERIS PHARMACEUTICALS INC.
PIRS
Seagen Inc.
SGEN
3,706,174
5.000%
0
(Unchanged)
View
2023-02-10
10:22 am
Unchanged
13GPIERIS PHARMACEUTICALS INC.
PIRS
ASTRAZENECA PLC
AZN
3,584,230
4.800%
0
(Unchanged)
View
2023-01-27
5:02 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Soleus Capital Master Fund L.P.4,000,000
5.400%
3,000,000increase
(+300.00%)
View
2023-01-26
5:01 pm
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Soleus Capital Master Fund L.P.1,000,000
1.300%
-2,884,868decrease
(-74.26%)
View
2022-10-24
4:57 pm
Purchase
13GPIERIS PHARMACEUTICALS INC.
PIRS
Lynx1 Capital Management LP3,824,619
5.100%
3,824,619increase
(New Position)
View
2022-02-14
3:20 pm
Sale
13GPIERIS PHARMACEUTICALS INC.
PIRS
Aquilo Capital Management LLC4,323,288
5.900%
-479,003decrease
(-9.97%)
View
Goto 0, 1, Next